Citation Impact
Citing Papers
Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors
2012
Psychological therapies for the management of chronic pain (excluding headache) in adults
2012 Standout
Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis
2004
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
1993
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Postmenopausal osteoporosis: patient choices and outcomes
1995
Child abuse: Adolescent records vs. adult recall
1990 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics
2011 Standout
Osteoporosis
2006
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
The assessment of vertebral deformity: A method for use in population studies and clinical trials
1993
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Design of the Fracture Intervention Trial
1993
Nondestructive determination of iliac crest cancellous bone strength by pQCT
1997
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Preventing fractures in elderly people
2003
Non-specific low back pain
2016 Standout
Vitamin D Deficiency
2007 Standout
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
2008
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
1993 Standout
Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome
1992
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures
1995
Intravenous pamidronate treatment in osteogenesis imperfecta
1997
Osteoporosis: now and the future
2011 Standout
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy
1993
Treatment of Postmenopausal Osteoporosis
1998
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
1999
Treatment of postmenopausal osteoporosis
2002
Treatment of Chronic Low Back Pain
2011
Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation
1998
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Pulsed electromagnetic energy treatment offers no clinical benefit in reducing the pain of knee osteoarthritis: a systematic review
2006
Should Prescription of Postmenopausal Hormone Therapy Be Based on the Results of Bone Densitometry?
1990
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Biomedical applications of bisphosphonates
2013
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
1992
A tense situation: forcing tumour progression
2009 Standout
Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age
1998
Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression
2002
A review of postgastrectomy bone disease
1992
Polymorphisms in the Sclerosteosis/van Buchem Disease Gene (SOST) Region Are Associated with Bone-Mineral Density in Elderly Whites
2004 StandoutNobel
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Management of patients on chronic glucocorticoid therapy: an endocrine perspective
2003
Suppression of bone formation by osteoclastic expression of semaphorin 4D
2011 Standout
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
2002 StandoutNature
Production and Actions of Estrogens
2002 Standout
Magnesium Deficiency in Alcoholism: Possible Contribution to Osteoporosis and Cardiovascular Disease in Alcoholics
1994
Osteoporosis: burden, health care provision and opportunities in the EU
2011
Strontium Ranelate: Dose-Dependent Effects in Established Postmenopausal Vertebral Osteoporosis—A 2-Year Randomized Placebo Controlled Trial
2002
Ghrelin: Structure and Function
2005 Standout
Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease
2000
Prevention of falls and consequent injuries in elderly people
2005 Standout
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
2008
Theoretical perspective: A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates
1996
Platelet aggregability in vivo is attenuated byverapamil but not bymetoprolol in patients with stable angina pectoris
1995
Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis
1996
The control of the false discovery rate in multiple testing under dependency
2001 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
Prevention of Nonvertebral Fractures by Alendronate
1997
Noninvasive assessment of bone mineral and structure: State of the art
1996
Different Effects of Calcium Antagonists, Nitrates, and β-Blockers on Platelet Function
1997
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Spinal and Supraspinal Factors in Human Muscle Fatigue
2001 Standout
Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use
2005
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1996
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Kinesio Taping applied to lumbar muscles influences clinical and electromyographic characteristics in chronic low back pain patients.
2011
Causal analysis approaches in Ingenuity Pathway Analysis
2013 Standout
Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models
1991
Coronary Plaque Disruption
1995 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib
2000
Alendronate Prevents Further Bone Loss in Renal Transplant Recipients
2001
Multidisciplinary biopsychosocial rehabilitation for chronic low back pain
2014
Effect of Calcitriol on Bone Loss After Cardiac or Lung Transplantation
2000
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
2002 Standout
Motor control exercise for chronic non-specific low-back pain
2016
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Bone metabolism and disease in chronic kidney disease
2003
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
1995
Long-Term Treatment of Incadronate Disodium Accumulates Microdamage but Improves the Trabecular Bone Microarchitecture in Dog Vertebra
2003
Bisphosphonates: Mechanisms of Action
1998
Creatine and Creatinine Metabolism
2000 Standout
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of Gorm Thamsborg being referenced
Comparison of a semiquantitative and a quantitative method for assessing vertebral fractures in osteoporosis
1994
Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis
1990
Treatment of knee osteoarthritis with pulsed electromagnetic fields: a randomized, double-blind, placebo-controlled study
2005
Dose-dependent effects of verapamil and nifedipine on in vivo platelet function in normal volunteers
1990
Bone Disorder in Men with Chronic Alcoholism: A Reversible Disease?
1991
Quantitation of urinary hydroxypyridinium cross-links from collagen by high-performance liquid chromatography
1992
Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis
1996
Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: A study of radiographic progression, inflammation on magnetic resonance imaging, and c
2011
Effect of different doses of nasal salmon calcitonin on bone mass
1991
Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis.
1996
Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women postmenopausal osteoporosis
1991
Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis
1993
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
1999
Treatment of Chronic Low Back Pain
2010
Effect of β1‐adrenoceptor blockade on plasma levels of atrial natriuretic peptide during exercise in normal man
1987